MGMT and laryngeal carcinoma: In the present study, it was identified that DNA hypermethylation-silenced MGMT in laryngeal carcinoma HEp-2 cells is characterized by H3K9 hypermethylation, and H3K9 and H3K4 hypomethylation at the promoter.